Indeed, the body weight of nude mice is not affected by Rad51 inactivation via daily IBR2 treatment (Supporting Information Fig S13), and IBR2 has no significant inhibitory effect on CD34+ normal bone marrow cells (Supporting Information Fig S12), suggesting that inhibition of RAD51 can be tumor-selective to a certain extent. The gene discussed is RAD51; the disease is neoplasm.